Reducing arrhythmic complications following alcohol septal ablation-The utility of lower doses of ethanol

Catheterization and Cardiovascular Interventions

Volumn 75, Issue 4, 2010, Pages 551-552

  Kimmelstiel, Carey ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL SEPTAL ABLATION; ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; COMPLETE HEART BLOCK; EDITORIAL; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LOW DRUG DOSE; POLYMORPHIC VENTRICULAR TACHYCARDIA;

CARDIOMYOPATHY, HYPERTROPHIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; HEART BLOCK; HEART CATHETERIZATION; HUMANS; INJECTIONS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77950544769     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22487     Document Type: Editorial

References (10)

1. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-258.
2. Veselka J, Zemanek D, Tomasov P, Homolova S, Adlova R, Tesar D. Complications of low-dose, echo-guided alcohol septal ablation. Catheter Cardiovasc Interv. DOI: 10.1002/ccd.22326.
3. Veselka J, Prochazkova S, Duchonova R, Bolomova-Homolova I, Palenickova J, Tesar D, Cervinka P, Honek T. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Catheter Cardiovasc Interv 2004;63:231-235.
4. Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Hartzell VS, Holmes DR Jr. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 2008;118:131-139.
5. Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A systematic review of published studies. J Interv Cardiol 2006;19:319-327. (Pubitemid 44185823)
6. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Circulation 1998;98:2415-2421.
7. Fernandes VL, Nielson C, Nagueh SF, Herrin AE, Slifka C, Franklin J, Spencer WH III. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy. JACC Cardiol Interv 2008;1:561-570.
8. Aqel R, Hage FG, AlJaroudi W, Lawson D, Sweeney A, Hansalia S, Pothineni K, Heo J, Pajaro O, McGiffin D, Dell'Italia L, Iskandrian AE. How much alcohol should we infuse in the coronary artery of hypertrophic cardiomyopathy patients? J Invasive Cardiol 2010;22:22-26.
9. Cucao FA, Spencer WH III, Fernandes AL, Nielson CD, Nagueh S, Sturdivant JL, Leman RB, Wharton JM, Gold MR. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol 2008;52:1718-1723.
10. Kimmelstiel CD, Maron BJ. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2004;109:452-455.